Lencioni R, Caramella D, Vignali C, Mazzeo S, Bagnolesi P, Cilotti A, Pinto F, Bartolozzi C
Istituto di Radiologia, Università degli Studi di Pisa.
Radiol Med. 1992 Nov;84(5):596-601.
Twenty-nine small hepatocellular carcinomas (sHCCs) less than 5 cm in diameter were treated with percutaneous ethanol injection (PEI) under US guidance in 24 cirrhotic patients. The nodules were treated on an outpatient basis with 6-18 ethanol injections; the total amount of alcohol delivered to each lesion was 10-103 ml. Twenty-seven of the 29 HCCs (93.1%) showed no evidence viable neoplastic tissue at a dynamic CT scan combined with multiple fine-needle biopsies performed one month after the end of treatment; in 10 cases MR confirmed the presence of necrosis showing marked hypointensity of the lesions in T2-weighted images. None of the 27 necrotized sHCCs recurred locally during a 4-44 months' follow-up period (mean 18 months). Two lesions larger than 4 cm showed incomplete response to treatment. No complications occurred after a total number of 264 alcohol injections. The 1-year survival rate in the 16 patients with a follow-up longer than 12 months was 93.7%. PEI proved to be a safe and effective treatment for sHCCs. In particular, PEI can be viewed as a reliable alternative to surgery in the management of nodules less than 3 cm in diameter, considering the operative hazards and the high risk of new lesions occurring in resected livers.
在超声引导下,对24例肝硬化患者的29个直径小于5 cm的小肝细胞癌(sHCC)进行了经皮乙醇注射(PEI)治疗。这些结节在门诊接受治疗,乙醇注射6 - 18次;每个病灶注入的乙醇总量为10 - 103 ml。治疗结束1个月后,29个HCC中的27个(93.1%)在动态CT扫描联合多次细针活检中未发现存活的肿瘤组织;10例患者的磁共振成像(MR)证实存在坏死,在T2加权图像中病灶呈明显低信号。在4 - 44个月的随访期(平均18个月)内,27个坏死的sHCC均未出现局部复发。2个大于4 cm的病灶治疗反应不完全。在总共264次乙醇注射后未发生并发症。16例随访时间超过12个月的患者1年生存率为93.7%。PEI被证明是治疗sHCC的一种安全有效的方法。特别是,考虑到手术风险以及切除肝脏中出现新病灶的高风险,对于直径小于3 cm的结节,PEI可被视为一种可靠的手术替代方法。